Literature DB >> 9365128

HCV infection in Egyptian patients with acute hepatitis.

I Quinti1, D el-Salman, M K Monier, B G Hackbart, M S Darwish, D el-Zamiaty, R Paganelli, F Pandolfi, R R Arthur.   

Abstract

The diagnostics of community-acquired acute HCV hepatitis in an endemic area was studied in 110 Egyptian patients with acute jaundice. In the first week of the jaundiced period 30 of 110 patients (27.3%) had anti-HCV antibodies. The majority already showed high levels of anti-HCV IgG (25/30), associated with anti-HCV IgM in nine of them. Five patients showed only an HCV IgM reactivity. Seven had also anti-HEV and/or anti-HBV: their jaundice could then be related to an acute infection caused by those viruses. All patients were infected with genotype 4a, in three associated with the 3a. During the follow-up five patients seroconverted for IgG, while their anti-HCV IgM did not show a uniform pattern of reactivity. Patients with positive serology suspected of an acute HCV infection were older than the patients with other acute hepatitis and showed a lower peak of ALT level. Seroconversion during acute hepatitis strongly indicated HCV as the etiologic agent. However, the detection of anti-HCV IgG antibodies in the jaundiced period showed that the majority of patients had already seroconverted to anti-HCV antibodies; in most of them it is possible to hypothesize a reactivation of a chronic HCV infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9365128     DOI: 10.1023/a:1018897813268

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  27 in total

1.  Diagnostic tests for hepatitis C: where are we now?

Authors:  V Tedeschi; L B Seeff
Journal:  Ann Intern Med       Date:  1995-09-01       Impact factor: 25.391

2.  HCV in Egypt in 1977.

Authors:  R R Arthur; I Z Imam; M D Saad; B G Hackbart; S B Mossad
Journal:  Lancet       Date:  1995-11-04       Impact factor: 79.321

3.  Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; J W Shih; J C Melpolder; M Houghton; Q L Choo; G Kuo
Journal:  N Engl J Med       Date:  1989-11-30       Impact factor: 91.245

4.  Hepatitis C virus-specific B cell activation: IgG and IgM detection in acute and chronic hepatitis C.

Authors:  I Quinti; N F Hassan; D El Salman; H Shalaby; D El Zimatty; M K Monier; R R Arthur
Journal:  J Hepatol       Date:  1995-12       Impact factor: 25.083

5.  Prevalence and significance of hepatitis C virus (HCV) viremia in HCV antibody-positive subjects from various populations.

Authors:  M François; F Dubois; D Brand; Y Bacq; C Guerois; C Mouchet; J Tichet; A Goudeau; F Barin
Journal:  J Clin Microbiol       Date:  1993-05       Impact factor: 5.948

6.  Assessment of hepatitis C viremia using molecular amplification technologies: correlations and clinical implications.

Authors:  D R Gretch; C dela Rosa; R L Carithers; R A Willson; B Williams; L Corey
Journal:  Ann Intern Med       Date:  1995-09-01       Impact factor: 25.391

7.  Transmission of hepatitis C in an isolated area in Japan: community-acquired infection. The South Kiso Hepatitis Study Group.

Authors:  K Kiyosawa; E Tanaka; T Sodeyama; K Yoshizawa; K Yabu; K Furuta; H Imai; Y Nakano; S Usuda; K Uemura
Journal:  Gastroenterology       Date:  1994-06       Impact factor: 22.682

8.  The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team.

Authors:  M J Alter; H S Margolis; K Krawczynski; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; M A Gerber; R E Sampliner
Journal:  N Engl J Med       Date:  1992-12-31       Impact factor: 91.245

9.  Importance of primer selection for the detection of hepatitis C virus RNA with the polymerase chain reaction assay.

Authors:  J Bukh; R H Purcell; R H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

10.  Antibodies and viremia in acute post-transfusion hepatitis C: a prospective study.

Authors:  T Peters; L Mohr; F Scheiffele; H J Schlayer; S Preisler; H Berthold; W Gerok; J Rasenack
Journal:  J Med Virol       Date:  1994-04       Impact factor: 2.327

View more
  4 in total

Review 1.  Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: an analysis using hepatitis C virus as a proxy biomarker.

Authors:  Yousra A Mohamoud; F DeWolfe Miller; Laith J Abu-Raddad
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

2.  Hepatitis C Virus NS5B Sequence-Based Genotyping Analysis of Patients From the Sharkia Governorate, Egypt.

Authors:  Ahmed Elsadek Fakhr; Mahmoud Reza Pourkarim; Piet Maes; Amal Hassan Atta; Ayman Marei; Magda Azab; Marc Van Ranst
Journal:  Hepat Mon       Date:  2013-12-17       Impact factor: 0.660

Review 3.  Hepatitis C virus viremic rate in the Middle East and North Africa: Systematic synthesis, meta-analyses, and meta-regressions.

Authors:  Manale Harfouche; Hiam Chemaitelly; Silva P Kouyoumjian; Sarwat Mahmud; Karima Chaabna; Zaina Al-Kanaani; Laith J Abu-Raddad
Journal:  PLoS One       Date:  2017-10-31       Impact factor: 3.240

Review 4.  Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions.

Authors:  Silva P Kouyoumjian; Hiam Chemaitelly; Laith J Abu-Raddad
Journal:  Sci Rep       Date:  2018-01-26       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.